Elizabeth Janiak, ScD, MA, MSc, Planned Parenthood League of Massachusetts
Background: Laws mandating parental consent or notification for minors seeking abortion currently affect girls in 38 states. Over the last three years, legislators proposed over 90 measures to introduce new or strengthen existing laws in 27 states. Despite their prevalence, parental involvement laws’ effects on girls’ access to and experience of abortion remain poorly described, ...Read more >
Depot medroxyprogesterone acetate (DMPA) is a progestin-only, hormonal contraceptive that is extremely effective, obviates the need for daily or weekly compliance, and can be used privately. DMPA is very appealing for the adolescent contraceptive user. Despite its many advantages, DMPA continuation rates are low in adolescents. Side effects, namely weight gain and bone mineral density ...Read more >
Julia Steinberg, PhD, University of California, San Francisco
Background: While prior research has shown that psychological health prior to an abortion is a strong predictor of post-abortion mental health and coping, research understanding the role of psychological health in other important post-abortion outcomes, such as contraceptive decision-making is lacking. Objective: The goal of this research is to examine how women’s levels of depression, ...Read more >
This project will assess the unmet demand for female sterilization in a sample of Mexican origin oral contraceptive users, as well the factors underlying that demand and the availability of this method of contraception in El Paso, Texas. It will build on the research findings and infrastructure of the project “Border Contraceptive Access Study,” in ...Read more >
Blair Darney, PhD, MPH, Oregon Health & Science University
Objectives: We describe payor for contraceptive visits and uptake of long-acting reversible contraception (LARC) during 2013 and 2014, before and after Affordable Care Act (ACA) implementation, in a network of diverse Community Health Centers (CHCs) and estimate the relative contributions of the ACA, Title X, and state 1115 or SPA family planning programs to insurance ...Read more >
Angel Foster, MD, DPhil, AM, Cambridge Reproductive Health Consultants
Background: The decades-long conflict, human rights violations, and lack of development in Eastern Burma have led to mass displacement of women from Burma into Thailand. These women face significant challenges accessing safe abortion care. Objectives: We evaluated two programs designed to reduce harm from unsafe abortion: a referral program in Northern Thailand and a misoprostol ...Read more >
All women can face obstacles when accessing reproductive health services. For some, obstacles are even greater. Over the last decade, Dr. Davis has created a network of researchers and clinicians dedicated to improving the reproductive health of two special populations: women with epilepsy seeking contraception and women in the second trimester of pregnancy seeking abortion. ...Read more >
Katherine Tumlinson, MA, University of North Carolina, Chapel Hill
Family planning has been shown to save the lives of women and children living in developing countries, yet it is estimated that between one third and nearly half of all women in developing countries using modern reversible contraceptive methods discontinue their method within 12 months of initiation. The objective of this study is to investigate ...Read more >
Objectives: To explore the prevalence of negative experiences with long-acting reversible contraception (LARC), shared by a friend or family member, and to assess the influence of these stories on decision-making. Methods: We performed a sub-study within a randomized controlled trial evaluating a contraceptive counseling intervention for women presenting for induced abortion (n=60). We surveyed participants ...Read more >
Corinne Rocca, PhD, MPH, University of California, San Francisco
Objectives: Expanding medication abortion to the pharmacy setting could help women access safe care. Studies have not evaluated pharmacy interventions. This non-inferiority study in Nepal investigated whether mifepristone-misoprostol medication abortion provided by trained nurses from pharmacies could be as effective and safe as when provided from government-certified abortion facilities. Methods: Nurses in two districts, Chitwan ...Read more >
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy